Qualigen Therapeutics Correlations

QLGN Stock

USD 3.25 0.03 0.93%

The current 90-days correlation between Qualigen Therapeutics and ZyVersa Therapeutics is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qualigen Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qualigen Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Qualigen Therapeutics Correlation With Market

Good diversification

The correlation between Qualigen Therapeutics and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.

Moving together with Qualigen Stock

0.71	CDIOW	Cardio Diagnostics	Pair Corr
0.75	ELVN	Enliven Therapeutics	Pair Corr
0.81	SCLX	Scilex Holding	Pair Corr
0.86	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.76	CDIO	Cardio Diagnostics	Pair Corr
0.69	CMND	Clearmind Medicine Common	Pair Corr
0.75	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.77	MSFT	Microsoft Aggressive Push	Pair Corr

Moving against Qualigen Stock

0.87	WM	Waste Management	Pair Corr
0.76	LUCD	Lucid Diagnostics	Pair Corr
0.76	GE	GE Aerospace	Pair Corr
0.64	PG	Procter Gamble	Pair Corr
0.54	PLX	Protalix Biotherapeutics	Pair Corr
0.87	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.87	T	ATT Inc Sell-off Trend	Pair Corr
0.79	IBM	International Business	Pair Corr
0.77	MMM	3M Company	Pair Corr
0.57	CSCO	Cisco Systems	Pair Corr
0.55	CVX	Chevron Corp	Pair Corr
0.47	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.38	INTC	Intel Sell-off Trend	Pair Corr
0.31	DD	Dupont De Nemours	Pair Corr

Related Correlations Analysis

	ZVSA	IMMX	PHIO	ATNF	NAVB	TCON	ARDS	ENTX	ANEB
ZVSA		0.44	0.5	0.34	0.0	0.0	0.0	0.73	0.05	ZVSA
IMMX	0.44		0.43	0.69	0.0	0.0	0.0	0.67	0.42	IMMX
PHIO	0.5	0.43		0.33	0.0	0.0	0.0	0.43	0.17	PHIO
ATNF	0.34	0.69	0.33		0.0	0.0	0.0	0.32	0.13	ATNF
NAVB	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	NAVB
TCON	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	TCON
ARDS	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	ARDS
ENTX	0.73	0.67	0.43	0.32	0.0	0.0	0.0		0.34	ENTX
ANEB	0.05	0.42	0.17	0.13	0.0	0.0	0.0	0.34		ANEB
	ZVSA	IMMX	PHIO	ATNF	NAVB	TCON	ARDS	ENTX	ANEB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ENTX	+ 0.73	ZVSA
ATNF	+ 0.69	IMMX
ENTX	+ 0.67	IMMX
PHIO	+ 0.5	ZVSA
IMMX	+ 0.44	ZVSA
PHIO	+ 0.43	IMMX

High negative correlations

ANEB	- 0.0	ARDS
ENTX	- 0.0	ARDS
ANEB	- 0.0	TCON
ENTX	- 0.0	TCON
ARDS	- 0.0	TCON
ANEB	- 0.0	NAVB

Risk-Adjusted Indicators

There is a big difference between Qualigen Stock performing well and Qualigen Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Qualigen Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	4.69	(0.23)	0.00	(0.57)	0.00	0.00	12.03	(8.20)	38.26
IMMX	3.32	0.00	0.01	0.82	3.97	(3.92)	6.82	(6.78)	26.42
PHIO	11.03	1.87	0.16	0.44	9.59	(20.71)	9.40	(10.59)	336.29
ATNF	4.37	(0.40)	0.00	(0.37)	0.00	0.00	7.62	(9.04)	79.11
NAVB	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TCON	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARDS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ENTX	3.44	(0.06)	0.00	(1.15)	0.00	0.00	8.50	(6.01)	27.97
ANEB	5.66	0.65	0.11	0.50	5.59	(8.10)	19.58	(10.43)	48.29

Qualigen Therapeutics Corporate Management

Christopher Lotz	VP Secretary	Profile
MD MBA	Senior Officer	Profile
Amy Broidrick	Chief Pres	Profile
Wajdi AbdulAhad	VP Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC